Roche

New Immunotherapy Coalition Launched in US

Roche Wins Patent Dispute Against Cipla

Roche Agrees Cancer Partnership with SQZ Biotech

Roche Exits Manufacturing Sites in Shift to Specialized Medicines

Modified Peptides

The folded structure of a protein defines its interactions with other molecules. Selective binding ligands could be, e.g., other proteins or peptides. A natural protein consists exclusively of L-amino acids and glycine, and its folded structure is chiral.

Pharma Players Mostly Lift 2015 Guidance

EU Commissions Backs New GSK Asthma Drug

UK Health Agency Blesses Merck Cancer Drug

Roche Agrees to Buy Kapa Biosystems to Boost Next-generation Portfolio

Pfizer Ranked Top Foreign Firm in UK Academic Research

Drugs Industry Battered by Currency and Competition

Welsh Biotech Start-up Raises Nearly £700,000

Roche Alzheimer and Breast Cancer Drugs Hit Snags

Bayer Fails to Block Cancer Generic in India

Roche's $8 billion InterMune Buy Not a Sign of More Big Deals

Lucentis and Avastin Said to Have Similar Side Effects

Managing Under Pressure

Roche to buy US Biotech Firm InterMune for $8.3 Billion

Roche Alzheimer's Drug Fails Main Goals in Mid-stage Study

Roche to Buy US Biotech Firm Seragon for up to $1.7 Billion

Roche Acquires DNA Sequencing Firm

Roche Invests 120 Million Swiss Francs at Basel

International Drugmakers Meet Challenges

Italy Goes After Criminal Drug Reselling Ring

Bayer and Reckitt Said Finalists for Merck & Co. Consumer Arm

Novartis and GlaxoSmithKline Swap $20 Billion in Assets

Roche Rejects Criticism of Tamiflu

GSK Combined Melanoma Treatment Delayed in Europe

Swiss Anti-Immigration Vote Could Impact Chemical Sector

The Biosimilar Market

Carlyle Said Close to Buying J&J Diagnostics Unit

Roche Wins FDA Approval for Breakthrough Leukemia Drug

Roche to Spend $880 Million on Manufacturing, Create 500 Jobs

Germany's Merck Sees Long-Term Growth in Cancer Drug Erbitux

Roche Breast Cancer Drug Gets U.S. Pre-Surgery Approval